Abstract
Thrombolysis is the treatment of choice for eligible acute stroke within 3 h after symptom onset. However, in the United States, only 2–5% of acute stroke patients receive this therapy, and among those patients who are treated there remains a risk of developing a symptomatic intracerebral hemorrhage (ICH) (1–3). Moreover, no treatment beyond 3 h has been approved by regulatory agencies. Thus, there is an urgent need to optimize safety and efficacy of thrombolytic therapy in the early time window (<3 h from onset), and identify selection criteria for therapies that can be safely extended into later time windows. Multimodal neuroimaging techniques are now available in the clinical setting and may provide an opportunity to meet both these needs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
NINDS rt-PA Stroke Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587
Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001;32:1832–1840
Johnston SC, Fung LH, Gillum LA, et al. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke 2001;32:1061–1068
Powers WJ, Zivin J. Magnetic resonance imaging in acute stroke: not ready for prime time [editorial; comment]. Neurology 1998;50:842–843
Liebeskind DS, Yang CK, Sayre J, Bakshi R. Neuroimaging of cerebral ischemia in clinical practice (abstract). Stroke 2003;34:255.
Ruland S, Gorelick PB, Schneck M, Kim D, Moore CG, Leurgans S. Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities. Stroke 2002;33:1334–1339
Schellinger PD, Jansen O, Fiebach JB, et al. Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. AJNR 2000;21:1184–1189
Sunshine JL, Tarr RW, Lanzieri CF, Landis DM, Selman WR, Lewin JS. Hyperacute stroke: ultrafast MR imaging to triage patients prior to therapy. Radiology 1999;212:325–332
Schellinger PD, Jansen O, Fiebach JB, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000;31:1318–1328
Mohr JP, Biller J, Hilal SK, et al. Magnetic resonance versus computed tomographic imaging in acute stroke. Stroke 1995;26:807–812
Moseley ME, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion-and T2-weighted MRI and spectroscopy. Magn Reson Med 1990;14:330–346
Latour LL, Warach S. Cerebral spinal fluid contamination of the measurement of the apparent diffusion coefficient of water in acute stroke. Magn Reson Med 2002;48:478–486
Kuelkens S, Schwark C, Schellinger PD, Fiebach JB, Ringleb PA, Hacke W. Systemic thombolysis in ischemic stroke 3 to 6 hours after onset of symptoms using a MR-based algorithm. Stroke 2003;34:247A.
Fiebach JB, Schellinger PD, Jansen O, et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002;33:2206–2210
Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330–1335.
Saur D, Kucinski T, Grzyska U, et al. Sensitivity and interrater agreement of CT and diffusion-weighted MR imaging in hyperacute stroke. AJNR Am J Neuroradiol 2003;24:878–885
Chalela JA, Latour LL, Jeffries N, Warach S. Hemorrhage and Early MRI Evaluation from Emergency Room (HEME-ER): a prospective, single center comparison of MRI to CT for the emergency diagnosis of intracranial hemorrhage in patients with suspected acute cerebrovascular disease. Stroke 2003;34:239–240
L^vblad KO, Laubach HJ, Baird AE, et al. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR 1998;19:1061–1066
Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion-and diffusion-weighted MRI. Neurology 1998;51:418–426
Warach S, Pettigrew LC, Dashe JF, et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 investigators. Ann Neurol 2000;48:713–722.
Kidwell CS, Alger JR, Di Salle F, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke 1999;30:1174–1180
Engelter ST, Provenzale JM, Petrella JR, Alberts MJ. Diffusion MR imaging and transient ischemic attacks [letter; comment]. Stroke 1999;30:2762–2763
Ay H, Oliveira-Filho J, Buonanno FS, et al. “Footprints” of transient ischemic attacks: a diffusion-weighted MRI study. Cerebrovasc Dis 2002;14:177–186
Takayama H, Mihara B, Kobayashi M, Hozumi A, Sadanaga H, Gomi S. [usefulness of diffusion-weighted MRI in the diagnosis of transient ischemic attacks]. No To Shinkei 2000;52:919–923.
Bisschops RHC, Kappelle LJ, Mali W, van der Grond J. Hemodynamic and metabolic changes in transient ischemic attack patients. Stroke 2001;33:110–115.
Rovira A, Rovira-Gols A, Pedraza S, Grive E, Molina C, Alvarez-Sabin J. Diffusion-weighted MR imaging in the acute phase of transient ischemic attacks. AJNR 2002;23:77–83.
Kamal AK, Segal AZ, Ulug AM. Quantitative diffusion-weighted MR imaging in transient ischemic attacks. AJNR 2002;23:1533–1538.
Warach S, Kidwell CS. The redefinition of TIA: the uses and limitations of dwi in acute ischemic cerebrovascular syndromes. Neurology 2004;62:359–360.
Kidwell CS, Warach S. Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke 2003;34:2995–2998.
Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magc Res Med 1990;14:249–265.
Baird AE, Lovblad KO, Dashe JF, et al. Clinical correlations of diffusion and perfusion lesion volumes in acute ischemic stroke. Cerebrovasc Dis 2000;10:441–448.
Schellinger PD, Fiebach JB, Jansen O, et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol 2001;49:460–469.
Broderick JP, Adams HP, Jr., Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999;30:905–915.
Adams HP, Jr., Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056–1083.
Atlas SW, Thulborn KR. MR detection of hyperacute parenchymal hemorrhage of the brain. AJNR 1998;19:1471–1477.
Fiebach JB, Schellinger PD, Gass A, et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 2004;35:502–506.
Kidwell CS, Chalela JA, Saver JL, Davis S, Starkman S, Warach S. Hemorrhage Early MRI Evaluation (HEME) study: preliminary results of a multicenter trial of neuroimaging in patients with acute stroke symptoms within 6 hours of onset (abstract). Stroke 2003;34:239.
Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, Hartung HP. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. 1999;20:637–642.
Fan YH, Zhang L, Lam WW, Mok VC, Wong KS. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 2003;34:2459–2462.
Kidwell CS, Saver JL, Villablanca JP, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 2002;33:95–98.
Chalela JA, Kang DW, Warach S. Cerebral microbleeds: MRI marker of a diffuse hemorrhage prone state. J Neuroimaging 2004;14:454–457.
Wiesmann M, Mayer TE, Yousry I, Medele R, Hamann GF, Bruckmann H. Detection of hyperacute subarachnoid hemorrhage of the brain by using magnetic resonance imaging. J Neurosurg 2002;96:684–689.
Singer MB, Atlas SW, Drayer BP. Subarachnoid space disease: diagnosis with fluid-attenuated inversion-recovery MR imaging and comparison with gadolinium-enhanced spin-echo MR imaging—blinded reader study. Radiology. 1998;208:417–422.
Mitchell P, Wilkinson ID, Hoggard N, et al. Detection of subarachnoid haemorrhage with magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2001;70:205–211.
Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia—the ischemic penumbra. Stroke 1981;12:723–725.
Warach S. Tissue viability thresholds in acute stroke: the 4-factor model. Stroke 2001;32:2460–2461.
Fisher M, Prichard JW, Warach S. New magnetic resonance techniques for acute ischemic stroke. JAMA 1995;274:908–911.
Schellinger PD. MRI-guided therapy in acute stroke. Expert Rev Cardiovasc Ther 2003;1:569–580.
Baird AE, Benfield A, Schlaug G, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;41:581–589.
Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996;16:53–59.
Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37:231–241.
Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI [letter]. Lancet 1999;353:2036–2037.
Parsons MW, Barber PA, Chalk J, et al. Diffusion-and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002;51:28–37.
Warach S, Investigators FTD. Early reperfusion related to clinical response in dias. International Stroke Conference, San Diego, CA. 2004.
Kidwell CS, Saver JL, Mattiello et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000;47:462–469.
Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003;34:2729–2735.
Wu O, Koroshetz WJ, Ostergaard L, et al. Predicting tissue outcome in acute human cerebralischemia using combined diffusion-and perfusion-weighted MR imaging. Stroke 2001;32:933–942.
Jacobs MA, Mitsias P, Soltanian-Zadeh H, et al. Multiparametric MRI tissue characterization in clinical stroke with correlation to clinical outcome: part 2. Stroke 2001;32:950–957.
Tong DC, Adami A, Moseley ME, Marks MP. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke 2000;31:2378–2384.
Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004;56(4):468–477.
Chalela JA, Kang DW, Luby M, et al. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol 2004;55:105–112.
Warach S. Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Curr Control Trials Cardiovasc Med 2001;2:38–44.
Schramm P, Schellinger PD, Klotz E, et al. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours’ duration. Stroke 2004;35:1652–1658.
Lev MH, Segal AZ, Farkas J, et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke 2001;32:2021–2028.
Wintermark M, Reichhart M, Thiran JP, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51:417–432.
Koenig M, Kraus M, Theek C, Klotz E, Gehlen W, Heuser L. Quantitative assessment of the ischemic brain by means of perfusion-related parameters derived from perfusion CT. Stroke 2001;32:431–437.
Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology 2000;55:1649–1655.
Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke trials. Lancet 2004;363:768–774.
Darby DG, Barber PA, Gerraty RP, et al. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 1999;30:2043–2052.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Schellinger, P.D., Kidwell, C.S., Warach, S. (2005). Using Magnetic Resonance Imaging to Select and Manage Patients for Treatment. In: Lyden, P.D. (eds) Thrombolytic Therapy for Acute Stroke. Current Clinical Neurology. Humana Press. https://doi.org/10.1385/1-59259-933-8:279
Download citation
DOI: https://doi.org/10.1385/1-59259-933-8:279
Publisher Name: Humana Press
Print ISBN: 978-1-58829-398-5
Online ISBN: 978-1-59259-933-2
eBook Packages: MedicineMedicine (R0)